EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Direct vagus nerve stimulation: A new tool to control allergic airway inflammation through α7 nicotinic acetylcholine receptor

Caroline Sévoz-Couche iD, Wupeng Liao iD, Hazel Y C Foo, Isabelle Bonne, Thong Beng Lu, Caris Tan Qi Hui, Syaza Hazwany Azhar, Wendy Yen Xian Peh, Shih-Cheng Yen, W S Fred Wong

British Journal of Pharmacology · 2024

DOI: 10.1111/bph.16334 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, 2024. Verfasst von Caroline Sévoz-Couche und 9 weiteren Autor:innen. Beteiligte Einrichtung: INSERM, UMRS1158 Neurophysiologie Respiratoire et Clinique, Sorbonne Université, Paris, France. Hauptthemen laut MEDLINE: alpha7 Nicotinic Acetylcholine Receptor, Vagus Nerve Stimulation, Mice, Inbred BALB C, Asthma. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation, National University Health System, National Research Foundation Singapore.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Asthma is characterized by airway inflammation, mucus hypersecretion, and airway hyperresponsiveness. The use of nicotinic agents to mimic the cholinergic anti‐inflammatory pathway (CAP) controls experimental asthma. Yet, the effects of vagus nerve stimulation (VNS)‐induced CAP on allergic inflammation remain unknown. Experimental Approach BALB/c mice were sensitized and challenged with house dust mite (HDM) extract and treated with active VNS (5 Hz, 0.5 ms, 0.05–1 mA). Bronchoalveolar lavage (BAL) fluid was assessed for total and differential cell counts and cytokine levels. Lungs were examined by histopathology and electron microscopy. Key Results In the HDM mouse asthma model, VNS at intensities equal to or above 0.1 mA (VNS 0.1) but not sham VNS reduced BAL fluid differential cell counts and alveolar macrophages expressing α7 nicotinic receptors (α7nAChR), goblet cell hyperplasia, and collagen deposition. Besides, VNS 0.1 also abated HDM‐induced elevation of type 2 cytokines IL‐4 and IL‐5 and was found to block the phosphorylation of transcription factor STAT6 and expression level of IRF4 in total lung lysates. Finally, VNS 0.1 abrogated methacholine‐induced hyperresponsiveness in asthma mice. Prior administration of α‐bungarotoxin, a specific inhibitor of α7nAChR, but not propranolol, a specific inhibitor of β2‐adrenoceptors, abolished the therapeutic effects of VNS 0.1. Conclusion and Implications Our data revealed the protective effects of VNS on various clinical features in allergic airway inflammation model. VNS, a clinically approved therapy for depression and epilepsy, appears to be a promising new strategy for controlling allergic asthma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha7 Nicotinic Acetylcholine ReceptorVagus Nerve StimulationMice, Inbred BALB CAsthmaAnimalsMiceBronchoalveolar Lavage FluidLungPyroglyphidaeInflammationCytokinesFemaleDisease Models, Animal

Stichwörter der Autor:innen

asthmabronchoalveolar inflammationnicotinic receptorsvagus nerve stimulation

Substanzen

alpha7 Nicotinic Acetylcholine ReceptorCytokines

Autor:innen und Institutionen

  • INSERM, UMRS1158 Neurophysiologie Respiratoire et Clinique, Sorbonne Université, Paris, France.
  • Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Singapore-HUJ Alliance for Research and Enterprise (SHARE), National University of Singapore, Singapore.
  • Electron Microscopy Unit, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Department of Microbiology & Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Advanced imaging and Histology Core, Immunology Program, Life Science Institute, National University of Singapore, Singapore.

ORCID-Profile: Caroline Sévoz-Couche, Wupeng Liao

Förderung

  • National Research Foundation
  • National University Health System
  • National Research Foundation Singapore

Zitieren

APA

Sévoz-Couche, C., Liao, W., Foo, H. Y. C., Bonne, I., Lu, T. B., Tan Qi Hui, C., Azhar, S. H., Peh, W. Y. X., Yen, S. C., & Wong, W. S. F. (2024). Direct vagus nerve stimulation: A new tool to control allergic airway inflammation through α7 nicotinic acetylcholine receptor. British Journal of Pharmacology. https://doi.org/10.1111/bph.16334

Vancouver

Sévoz-Couche C, Liao W, Foo HYC, Bonne I, Lu TB, Tan Qi Hui C, et al. Direct vagus nerve stimulation: A new tool to control allergic airway inflammation through α7 nicotinic acetylcholine receptor. British Journal of Pharmacology. 2024. doi:10.1111/bph.16334

BibTeX
@article{SvozCouche2024,
  author = {Sévoz-Couche, Caroline and Liao, Wupeng and Foo, Hazel Y C and Bonne, Isabelle and Lu, Thong Beng and Tan Qi Hui, Caris and Azhar, Syaza Hazwany and Peh, Wendy Yen Xian and Yen, Shih-Cheng and Wong, W S Fred},
  title = {Direct vagus nerve stimulation: A new tool to control allergic airway inflammation through α7 nicotinic acetylcholine receptor},
  journal = {British Journal of Pharmacology},
  year = {2024},
  doi = {10.1111/bph.16334}
}
Kostenlos starten →